IP Verse

Trishula Therapeutics competitive analysis

Loading summary...

Latest oppositions filed by Trishula Therapeutics

Explore patent oppositions filed by Trishula Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3153526
Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 23, 2021

Latest publications and patents of Trishula Therapeutics New

Explore the latest publications and patents granted to Trishula Therapeutics, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Trishula Therapeutics

Discover the latest PTAB cases involving Trishula Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Trishula Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TRISHULA THERAPEUTICS1 - - -
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 36 - -